Astragaloside IV Confers Prophylactic Efficacy Against Depression Associated with the ROS/Nrf2/Keap1 Axis: Modulation of Oxidative Stress and Energy Homeostasis
Antioxidants & Redox Signaling · 01.06.2026 · 44 (16-18) · 822-842
DOI: 10.1177/15230864261428133 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antioxidants & Redox Signaling, online erschienen am 18.03.2026. Verfasst von Jiaxue Tian und 6 weiteren Autor:innen. Beteiligte Einrichtung: Modern Research Center for Traditional Chinese Medicine, Shanxi University, Taiyuan, China. Hauptthemen laut MEDLINE: Saponins, Triterpenes, NF-E2-Related Factor 2, Oxidative Stress. Die Arbeit nennt 58 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Themen: Depression
Abstract (Originalsprache)
Aims
Depression is a prevalent mood disorder with significant suffering and heightened suicide risk. Accumulating evidence points to oxidative stress and impaired energy metabolism of the brain as key contributors to the pathogenesis of depression. Astragaloside IV (AIV) has been demonstrated to alleviate neurological damage. The capacity of AIV for antioxidation has also been gradually discovered. Yet, it still just scratches the surface of the antidepression mechanisms of AIV. Our aim was to explore a novel mechanism of action of AIV from the perspectives of redox homeostasis and energy metabolism via the reactive oxygen species (ROS)/nuclear factor erythroid 2-related factor 2 (Nrf2)/Kelch-like ECH-associated protein 1 (Keap1) axis.
Results
AIV ameliorated anxiety and cognitive dysfunction in rats with depression-like behaviors. Furthermore, we illustrated that AIV reversed redox dyshomeostasis of rats with depression-like behaviors in terms of decreasing the level of malondialdehyde while increasing the abundances of catalase, superoxide dismutase, and glutathione peroxidase. In addition, AIV significantly increased the levels of indicators of energy metabolism that were interrupted by depression. Furthermore, in vitro , AIV significantly increased the levels of indicators related to the Nrf2/Keap1 signaling pathway in corticosterone-induced PC12 cells. Innovation: For the first time, it demonstrates that AIV alleviates depression by modulating the ROS/Nrf2/Keap1 axis and restoring hippocampal energy metabolism in a chronic unpredictable mild stress model.
Conclusion
The current findings not only offer novel insights into antidepressant-like effects of AIV through the ROS/Nrf2/Keap1 axis but also provide a foundation for enhancing clinical efficiency and enriching drug selection. Antioxid. Redox Signal. 44, 822–842.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Modern Research Center for Traditional Chinese Medicine, Shanxi University, Taiyuan, China.
- Key Laboratory of Research and Utilization of Bioactive Components in Famous Shanxi Medicinal Materials, Shanxi University, Taiyuan, China.
ORCID-Profile: Xiaojie Liu
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Tian, J., Wang, H., Liu, H., Xu, W., Xiao, M., Qin, X., & Liu, X. (2026). Astragaloside IV Confers Prophylactic Efficacy Against Depression Associated with the ROS/Nrf2/Keap1 Axis: Modulation of Oxidative Stress and Energy Homeostasis. Antioxidants & Redox Signaling, 44(16-18), 822-842. https://doi.org/10.1177/15230864261428133
Vancouver
Tian J, Wang H, Liu H, Xu W, Xiao M, Qin X, et al. Astragaloside IV Confers Prophylactic Efficacy Against Depression Associated with the ROS/Nrf2/Keap1 Axis: Modulation of Oxidative Stress and Energy Homeostasis. Antioxidants & Redox Signaling. 2026;44(16-18):822-842. doi:10.1177/15230864261428133
BibTeX
@article{Tian2026,
author = {Tian, Jiaxue and Wang, Huimin and Liu, Huimin and Xu, Wenlu and Xiao, Mengting and Qin, Xuemei and Liu, Xiaojie},
title = {Astragaloside IV Confers Prophylactic Efficacy Against Depression Associated with the ROS/Nrf2/Keap1 Axis: Modulation of Oxidative Stress and Energy Homeostasis},
journal = {Antioxidants & Redox Signaling},
year = {2026},
volume = {44},
number = {16-18},
pages = {822--842},
doi = {10.1177/15230864261428133}
}
EUVIMED